Cited by 265Cardiovascular Disease and AdiposityHeart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

Epicardial fat in heart failure patients with mid-range and preserved ejection fraction

Open access
van Woerden, Gijs, Gorter, Thomas M., Westenbrink, B. Daan, Willems, Tineke P., van Veldhuisen, Dirk J., Rienstra, Michiel·2018·European Journal of Heart Failure

Abstract

Abstract Aims Adipose tissue and inflammation may play a role in the pathophysiology of patients with heart failure (HF) with mildly reduced or preserved ejection fraction. We therefore investigated epicardial fat in patients with HF with preserved (HFpEF) and mid-range ejection fraction (HFmrEF), and related this to co-morbidities, plasma biomarkers and cardiac structure. Methods and results A total of 64 HF patients with left ventricular ejection fraction >40% and 20 controls underwent routine cardiac magnetic resonance examination. Epicardial fat volume was quantified on short-axis cine stacks covering the entire epicardium and was related to clinical correlates, biomarkers associated with inflammation and myocardial injury, and cardiac function and contractility on cardiac magnetic resonance. HF patients and controls were of comparable age, sex and body mass index. Total epicardial fat volume was significantly higher in HF patients compared to controls (107 mL/m2 vs. 77 mL/m2, P <0.0001). HF patients with atrial fibrillation and/or type 2 diabetes mellitus had more epicardial fat than HF patients without these co-morbidities (116 vs. 100 mL/m2, P =0.03, and 120 vs. 97 mL/m2, P =0.001, respectively). Creatine kinase-MB, troponin T and glycated haemoglobin in patients with HF were positively correlated with epicardial fat volume (R =0.37, P =0.006; R =0.35, P =0.01; and R =0.42, P =0.002, respectively). Conclusion Heart failure patients had more epicardial fat compared to controls, despite similar body mass index. Epicardial fat volume was associated with the presence of atrial fibrillation and type 2 diabetes mellitus and with biomarkers related to myocardial injury. The clinical implications of these findings are unclear, but warrant further investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ejhf.1283

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
van Woerden, G., Gorter, T. M., Westenbrink, B. D., Willems, T. P., van Veldhuisen, D. J., & Rienstra, M.
Affiliations
  • Department of Cardiology, University of Groningen, University Medical Center Groningen , Groningen ,
  • University Medical Center Groningen (NL)
Corresponding author
Rienstra, Michiel
Venue
European Journal of Heart Failure
Published
2018-08-01
Volume
20
Issue
11
Pages
1559-1566
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2886821858
Cited by
265
References
34
Citations by year
2026: 12 · 2025: 38 · 2024: 40 · 2023: 45 · 2022: 35 · 2021: 36 · 2020: 34 · 2019: 21 · 2018: 3
FWCI
17.75
Type
journal article
Language
en
Open access
Locations
  • European Journal of Heart Failure (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by-nc)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc)
Funders
Abbott Netherlands
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords
epicardial adipose tissue, heart failure with preserved ejection fraction, heart failure with mildly reduced ejection fraction, adipose tissue, inflammation, atrial fibrillation, type 2 diabetes, myocardial injury biomarkers, troponin T, creatine kinase-MB, HbA1c, cardiac magnetic resonance, cardiac structure
MeSH terms
Adipose Tissue, Aged, Echocardiography, Female, Heart Failure, Humans, Male, Peptide Fragments, Pericardium, Prognosis, Stroke Volume, Biomarkers, Ventricular Function, Left, Magnetic Resonance Imaging, Cine, Natriuretic Peptide, Brain, Troponin T

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review